Tomas G. Neilan

Myocarditis in Patients Treated With Immune Checkpoint Inhibitors

Syed Mahmood, Michael G. Fradley, Justine V. Cohen et al. · Journal of the American College of Cardiology · 2018 · 1.5K citations · Full text

Heart Failure, Autoimmune Disease, Immune Checkpoint Inhibitors +7

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

John H. Stone, Matthew J. Frigault, Naomi Serling‐Boyd et al. · New England Journal of Medicine · 2020 · 1.4K citations · Full text

Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society

Alexander R. Lyon, Susan Dent, Susannah Stanway et al. · European Journal of Heart Failure · 2020 · 717 citations · Full text

Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement

Joerg Herrmann, Daniel J. Lenihan, Saro H. Armenian et al. · European Heart Journal · 2021 · 542 citations · Full text

Heart Failure, Oncology, Cardiovascular Toxicities +15

Myocardial Injury and Ventricular Dysfunction Related to Training Levels Among Nonelite Participants in the Boston Marathon

Tomas G. Neilan, James L. Januzzi, Elizabeth Lee-Lewandrowski et al. · Circulation · 2006 · 515 citations · Full text